Research Directory

Immunotherapies show positive data at ESMO

Read more

ASCO 2024

Read more

New oncology drugs in pre-registration, late stage development

Read more

Oncology Review: New drugs for myeloma, breast cancer reached the market in 2023

Read more

ESMO: New drug combinations show promise for cancer

Read more

Drugs for lung cancers and leukaemia break new ground

Read more

ASCO 2023 Strong data for lung and breast cancer drugs

Read more

Development timelines for new oncology drugs

Read more

Oncology pipeline marked by multiple therapy types

Read more

Novel oncology drugs approved in a year of change

Read more